WO2001054735A3 - Gel-infused sponges for tissue repair and augmentation - Google Patents

Gel-infused sponges for tissue repair and augmentation Download PDF

Info

Publication number
WO2001054735A3
WO2001054735A3 PCT/US2001/002837 US0102837W WO0154735A3 WO 2001054735 A3 WO2001054735 A3 WO 2001054735A3 US 0102837 W US0102837 W US 0102837W WO 0154735 A3 WO0154735 A3 WO 0154735A3
Authority
WO
WIPO (PCT)
Prior art keywords
gel
augmentation
tissue repair
infused
sponges
Prior art date
Application number
PCT/US2001/002837
Other languages
French (fr)
Other versions
WO2001054735A2 (en
Inventor
Hanne Bentz
A Minerva Garcia
Jeffrey A Hubbell
Original Assignee
Orthogene Inc
Hanne Bentz
A Minerva Garcia
Jeffrey A Hubbell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogene Inc, Hanne Bentz, A Minerva Garcia, Jeffrey A Hubbell filed Critical Orthogene Inc
Priority to AU2001234623A priority Critical patent/AU2001234623A1/en
Publication of WO2001054735A2 publication Critical patent/WO2001054735A2/en
Publication of WO2001054735A3 publication Critical patent/WO2001054735A3/en
Priority to US10/207,439 priority patent/US20030095993A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Abstract

Gel-infused sponge matrix comprising an absorbable sponge material, a gel and an active ingredient are disclosed, as are methods of enhancing tissue repair, regeneration or augmentation using the gel-infused sponge.
PCT/US2001/002837 2000-01-28 2001-01-26 Gel-infused sponges for tissue repair and augmentation WO2001054735A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001234623A AU2001234623A1 (en) 2000-01-28 2001-01-26 Gel-infused sponges for tissue repair and augmentation
US10/207,439 US20030095993A1 (en) 2000-01-28 2002-07-26 Gel-infused sponges for tissue repair and augmentation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17864600P 2000-01-28 2000-01-28
US60/178,646 2000-01-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/207,439 Continuation US20030095993A1 (en) 2000-01-28 2002-07-26 Gel-infused sponges for tissue repair and augmentation

Publications (2)

Publication Number Publication Date
WO2001054735A2 WO2001054735A2 (en) 2001-08-02
WO2001054735A3 true WO2001054735A3 (en) 2001-12-20

Family

ID=22653340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002837 WO2001054735A2 (en) 2000-01-28 2001-01-26 Gel-infused sponges for tissue repair and augmentation

Country Status (2)

Country Link
AU (1) AU2001234623A1 (en)
WO (1) WO2001054735A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599515B1 (en) * 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
US6965014B1 (en) 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
US20140193468A1 (en) * 2001-03-23 2014-07-10 Histogenics Corporation Methods for preparation of neo-cartilage constructs
JP3646162B2 (en) * 2001-07-04 2005-05-11 独立行政法人産業技術総合研究所 Transplant for cartilage tissue regeneration
DE102005030614B4 (en) 2005-06-30 2014-05-08 Biotissue Ag Cell-free graft, its use, process for its preparation, matrix thus produced with gel and process for the preparation of this matrix with gel
US20070196342A1 (en) * 2005-12-14 2007-08-23 Sadozai Khalid K Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
US20070202084A1 (en) * 2005-12-14 2007-08-30 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
WO2007103208A2 (en) * 2006-03-01 2007-09-13 Fmc Biopolymer As Biodegradable foam
DE102006047346A1 (en) * 2006-10-06 2008-04-10 Transtissue Technologies Gmbh Matrix gel graft without cells
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US9855372B2 (en) 2008-10-17 2018-01-02 Sofradim Production Auto-sealant matrix for tissue repair
CA2781591A1 (en) 2008-11-24 2010-05-27 Schubert Holdings Llc Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
EP2398519A2 (en) 2009-02-21 2011-12-28 Sofradim Production Compounds and medical devices activated with solvophobic linkers
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
JP6390873B2 (en) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス Dry composition expanded under reduced pressure and syringe for holding the same
RU2678592C1 (en) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Dry composition comprising extrusion enhancer
BR112017007466B1 (en) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S method for preparing a dry composition, method for reconstituting the dry composition, paste, dry composition, container, homeostatic kit, and, using a dry composition
JP6747650B2 (en) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding and mixing the first substance and the second substance
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11129790B2 (en) 2017-05-19 2021-09-28 Northeastern University Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
KR20210008479A (en) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 How to prepare a hemostatic composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451397A (en) * 1981-11-30 1984-05-29 Centre Technique Du Cuir Method of preparing collagen products
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
FR2657352A1 (en) * 1990-01-25 1991-07-26 France Etat Armement New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
WO1996025961A1 (en) * 1995-02-22 1996-08-29 Ed Geistlich Söhne Ag Für Chemische Industrie Resorbable extracellular matrix for reconstruction of cartilage tissue
US5645849A (en) * 1993-11-03 1997-07-08 Clarion Pharmaceuticals, Inc. Hemostatic patch
WO1998040111A1 (en) * 1997-03-07 1998-09-17 University College London Tissue implant

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451397A (en) * 1981-11-30 1984-05-29 Centre Technique Du Cuir Method of preparing collagen products
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
FR2657352A1 (en) * 1990-01-25 1991-07-26 France Etat Armement New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5645849A (en) * 1993-11-03 1997-07-08 Clarion Pharmaceuticals, Inc. Hemostatic patch
WO1996025961A1 (en) * 1995-02-22 1996-08-29 Ed Geistlich Söhne Ag Für Chemische Industrie Resorbable extracellular matrix for reconstruction of cartilage tissue
WO1998040111A1 (en) * 1997-03-07 1998-09-17 University College London Tissue implant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition

Also Published As

Publication number Publication date
AU2001234623A1 (en) 2001-08-07
WO2001054735A2 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
WO2001054735A3 (en) Gel-infused sponges for tissue repair and augmentation
AU2051000A (en) Methods for soft tissue augmentation
AU2003277243A1 (en) Tissue mimicking elastography phantoms
AU2002343561A1 (en) Composition and method for growing, protecting, and healing tissues and cells
MXPA03006753A (en) Soft absorbent tissue.
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
AU2003289475A1 (en) Cell handling device, human tissue regeneration composition, and human tissue regeneration method
AU2003266286A1 (en) Laser-based device for non-mechanical, three-dimensional trepanation during cornea transplants
AU2003213367A1 (en) Base material for tissue regeneration, transplantation material and process for producing the same
AU2002229087A1 (en) Skin disinfectant applicator
AU2003252299A1 (en) Novel physiologically active substance
AU2001215528A1 (en) Base materials for tissue regeneration, transplant materials and process for producing the same
MXPA02001613A (en) Tissue augmentation material and methods.
CA2406057A1 (en) Methods and compositions for modulating alpha adrenergic receptor activity
AU2001248215A1 (en) Cosmetically active composition
AU2271400A (en) Composition, kit, method and device for hair treatment
AU5117400A (en) Tip structures, devices on their basis, and methods for their preparation
AU2003210515A1 (en) Methods for sterilizing tissue
AU2003223003A1 (en) An assembly for use in orthopaedic surgery
ZA993035B (en) Surgical nail forceps.
BRPI0209619B8 (en) hair growth promoting agent
AU2003214381A1 (en) Perfume gel composition
AU2003300435A1 (en) Tissue and organ preservation, protection and resuscitation
WO2003084499A3 (en) Gel cleaning preparations comprising pre-gelatinised, cross-linked starch derivatives and polyacrylates
AU2002220396A1 (en) Filler composition for soft tissue augmentation and reconstructive surgery

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10207439

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP